Gilead Defective Drug FCA Suit Tossed For Second Time
Changes to a False Claims Act lawsuit alleging Gilead Sciences Inc. sought Medicare and Medicaid reimbursement for shoddily made drugs were not enough to save it in California federal court Friday,...To view the full article, register now.
Already a subscriber? Click here to view full article